FilingReader Intelligence

Dalian Bio-Chem's share buyback hits CNY 111.5m, progresses towards employee plans

September 4, 2025 at 11:21 AM UTCBy FilingReader AI

As of September 4, 2025, Dalian Bio-Chem has repurchased 5,365,500 shares through centralized bidding, representing 0.76% of its total share capital. The total value of these repurchases amounts to CNY 111,559,033.92 (excluding transaction fees), with prices ranging from CNY 19.58 to CNY 24.03 per share. This initiative aligns with the company's previously announced plan to buy back shares for employee stock ownership or equity incentive programs.

The share repurchase program was initially approved by the board on April 24, 2025, with an expected expenditure of CNY 200 million to CNY 400 million over a 12-month period. Following a 2024 annual equity distribution, the maximum repurchase price per share was adjusted from CNY 44.94 to CNY 31.67.

Dalian Bio-Chem will continue to monitor market conditions and adhere to regulatory guidelines for its share buyback program, committing to timely disclosure of progress to investors.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SSE:603360Shanghai Stock Exchange

News Alerts

Get instant email alerts when Dalian Bio-Chem publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →